Leave your feedback Share Copy URL https://mypepack.gophersport.com/video/?vid=0rmEh7of5pN Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [isotvOH17Mb] Health Updated on August 11, 2026 EDT — Published on August 11, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. 48jCDG8oZbF oYbZaT1UvcI 2DoLi2SipcB yssnuTUV4yc 9pyYkxBuSUo XGb5l0Ipsp2 tG7149MKz47 AzBWazrhJa6
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. 48jCDG8oZbF oYbZaT1UvcI 2DoLi2SipcB yssnuTUV4yc 9pyYkxBuSUo XGb5l0Ipsp2 tG7149MKz47 AzBWazrhJa6